GO:0036066 protein O-linked glycosylation via fucose: Protein Modification Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036066 (protein O-linked glycosylation via fucose) describes the enzymatic addition of fucose to serine or threonine residues of proteins, typically within EGF-like or thrombospondin type-1 repeats.
• This modification is catalyzed by protein O-fucosyltransferases (POFUT1 and POFUT2) and can be further elongated by glycosyltransferases such as POGLUT1 and B3GLCT.
• O-fucosylation is essential for Notch signaling, as it modulates ligand-receptor interactions and downstream transcriptional programs.
• Dysregulation of O-fucosylation is linked to human diseases including cancer, inflammatory bowel disease, and developmental disorders.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise interrogation of O-fucosylation genes in health and disease.
• Advanced methods such as fucosyl-biotinylation, glycoproteomics, and lectin-based imaging allow detection and quantification of O-fucosylation in cells and tissues.
Description
Protein O-linked glycosylation via fucose (GO:0036066) is a conserved post-translational modification in which fucose is covalently attached to the hydroxyl group of serine or threonine residues on target proteins. This process typically occurs within specific consensus motifs, such as EGF-like repeats and thrombospondin type-1 repeats, and serves as a critical regulator of protein folding, stability, and interactions. The modification is initiated by protein O-fucosyltransferases, which transfer fucose from GDP-fucose to the protein backbone, and can be further extended by other glycosyltransferases to form complex O-linked glycans. O-fucosylation plays indispensable roles in metazoan development and physiology. It is required for Notch signaling, where O-fucose glycans on Notch receptors modulate ligand binding and activation. Beyond Notch, O-fucosylation influences diverse processes such as intestinal stem cell homeostasis, ciliogenesis, and immune responses. Aberrant O-fucosylation has been implicated in cancer, inflammatory diseases, and congenital disorders, making it a compelling target for therapeutic intervention and biomarker discovery. For researchers, GO:0036066 provides a framework to study the enzymes, substrates, and biological consequences of this modification. Understanding its molecular mechanisms and regulation is essential for deciphering its roles in development and disease, and for designing experiments that manipulate O-fucosylation using CRISPR and other advanced technologies.
protein O-linked glycosylation via fucose At A Glance
| GO ID | GO:0036066 |
|---|---|
| GO term | protein O-linked glycosylation via fucose |
| Ontology | biological_process |
| Synonym | protein O-linked fucosylation |
| Major function | Covalent attachment of fucose to serine/threonine residues on proteins, often within EGF-like or thrombospondin type-1 repeats, influencing protein function and signaling. |
| Enzymes involved | POFUT1, POFUT2 (initiating); POGLUT1, B3GLCT, FUT8, FUT2 (elongating/modifying). |
| Subcellular location | Endoplasmic reticulum and Golgi apparatus. |
| Key protein targets | Notch receptors, thrombospondin type-1 repeat-containing proteins, and other EGF-repeat proteins. |
| Related diseases | Cancer, inflammatory bowel disease, sepsis, developmental disorders. |
What Is GO:0036066?
GO:0036066, protein O-linked glycosylation via fucose, is defined as a glycoprotein biosynthetic process that begins with the covalent attachment of a fucose molecule via an alpha-glycosidic bond to the oxygen atom of a serine or threonine residue in a protein. This initial step can be followed by the sequential addition of other sugar units, leading to the formation of an elongated O-linked glycan. The modification typically occurs within specific protein motifs, such as EGF-like repeats or thrombospondin type-1 repeats.
Why Is protein O-linked glycosylation via fucose Important in Cell Biology?
Protein O-linked glycosylation via fucose is a fundamental post-translational modification that regulates the function of numerous secreted and membrane proteins. It is essential for Notch signaling, a pathway controlling cell fate decisions during development and tissue homeostasis. Dysregulation of O-fucosylation has been linked to a spectrum of human diseases, including cancer, inflammatory conditions, and congenital disorders of glycosylation. Studying this process provides insights into basic cell biology and offers potential targets for therapeutic intervention and biomarker development.
• Essential for Notch signaling and cell fate determination during development.
• Modulates protein stability, folding, and trafficking in the secretory pathway.
• Implicated in cancer progression and metastasis through altered glycosylation.
• Plays a role in intestinal stem cell protection against inflammatory injury.
• Involved in ciliogenesis and ciliary function via stabilization of TMEM67.
• Contributes to immune responses and inflammation, as seen in sepsis and allergy.
• Mutations in O-fucosylation enzymes cause developmental disorders such as Dowling-Degos disease and Peters plus syndrome.
• Serves as a target for glycoengineering and therapeutic antibody development.
• Enables detection of tumor antigen-specific T cells via fucosyl-biotinylation.
• Provides a model for studying glycosyltransferase specificity and regulation.
What Happens During protein O-linked glycosylation via fucose?
Initiation by O-Fucosyltransferases
In simple terms: The first step is the attachment of a fucose sugar to a protein.
The process begins in the endoplasmic reticulum (ER) with the transfer of fucose from GDP-fucose to the hydroxyl group of serine or threonine residues on target proteins. This reaction is catalyzed by protein O-fucosyltransferases, primarily POFUT1 and POFUT2, which recognize specific consensus sequences within EGF-like repeats or thrombospondin type-1 repeats. POFUT1 targets EGF repeats, while POFUT2 modifies thrombospondin type-1 repeats. This initial fucosylation is essential for subsequent glycan elongation and for the biological function of the modified proteins.
Elongation of O-Fucose Glycans
In simple terms: Additional sugars are added to the fucose to build a larger glycan chain.
Following the initial fucosylation, the O-fucose moiety can be extended by other glycosyltransferases. For example, POGLUT1 adds glucose to O-fucose on EGF repeats, and B3GLCT adds glucose to O-fucose on thrombospondin type-1 repeats, forming a disaccharide that can be further elongated. These elongation steps occur in the ER and Golgi and are critical for modulating protein function, as the extended glycans can influence ligand binding and receptor activation, particularly in Notch signaling.
Regulation of Notch Signaling
In simple terms: The fucose sugar on Notch receptors controls how they respond to signals.
O-fucosylation of Notch receptors is essential for their interaction with ligands such as DLL1 and DLL4. The addition of fucose and its subsequent elongation directly affects Notch receptor activation and downstream signaling. Studies have shown that differential O-glucose elongation on specific EGF repeats within the ligand-binding domain regulates DLL1/4-NOTCH1 signaling, highlighting the fine-tuning role of O-glycans in this pathway. Disruption of O-fucosylation leads to defective Notch signaling and developmental abnormalities.
Biological Consequences and Disease Links
In simple terms: When this process goes wrong, it can lead to various diseases.
O-fucosylation impacts diverse physiological processes. FUT2-dependent fucosylation of HYOU1 protects intestinal stem cells against inflammatory injury by regulating the unfolded protein response. FUT8-mediated core fucosylation stabilizes TMEM67 to promote ciliogenesis, linking O-fucosylation to ciliary biology. Fucosylated haptoglobin promotes inflammation via Mincle in sepsis, indicating a role in immune modulation. Additionally, O-fucosylation is implicated in cancer, where altered glycosylation patterns can affect tumor progression and immune recognition.
Key Genes Involved in GO:0036066 protein O-linked glycosylation via fucose
The following genes encode enzymes and proteins directly involved in protein O-linked glycosylation via fucose, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| POFUT1 | Initiates O-fucosylation on EGF-like repeats | Essential for Notch signaling; knockout causes embryonic lethality. |
| POFUT2 | Initiates O-fucosylation on thrombospondin type-1 repeats | Required for secretion of TSR-containing proteins; mutations cause Peters plus syndrome. |
| POGLUT1 | Elongates O-fucose by adding glucose on EGF repeats | Modulates Notch signaling; mutations linked to Dowling-Degos disease. |
| B3GLCT | Elongates O-fucose on TSRs by adding glucose | Deficiency causes Peters plus syndrome; involved in protein folding. |
| FUT8 | Catalyzes core fucosylation of N-glycans | Stabilizes TMEM67 to promote ciliogenesis; implicated in cancer and immune regulation. |
| FUT2 | Mediates fucosylation of HYOU1 | Protects intestinal stem cells against inflammatory injury via UPR regulation. |
| NOTCH1 | Transmembrane receptor modified by O-fucosylation | O-fucose glycans regulate ligand binding and activation. |
| DLL1 | Notch ligand | O-glucose elongation on EGF repeats affects DLL1-NOTCH1 signaling. |
| DLL4 | Notch ligand | O-fucose modifications influence DLL4-NOTCH1 interaction. |
| HYOU1 | ER stress protein | FUT2-dependent fucosylation protects intestinal stem cells. |
| TMEM67 | Ciliary protein | FUT8-mediated fucosylation stabilizes TMEM67 for ciliogenesis. |
| Haptoglobin | Acute-phase protein | Fucosylated haptoglobin promotes inflammation via Mincle in sepsis. |
| Mincle | C-type lectin receptor | Recognizes fucosylated haptoglobin to drive inflammation. |
| GDP-fucose transporter | Transports GDP-fucose into ER/Golgi | Required for substrate availability for fucosyltransferases. |
| FX | GDP-fucose synthesis enzyme | Provides GDP-fucose for O-fucosylation. |
| GMD | GDP-fucose synthesis enzyme | Involved in de novo GDP-fucose production. |
| GNPTAB | GlcNAc-1-phosphotransferase | Indirectly affects glycosylation pathways. |
| B4GALT1 | Beta-1,4-galactosyltransferase | May elongate O-fucose glycans in some contexts. |
How Is protein O-linked glycosylation via fucose Regulated?
O-fucosylation is regulated at multiple levels. The availability of the substrate GDP-fucose, synthesized via the de novo and salvage pathways, controls the rate of fucosylation. Expression levels of POFUT1 and POFUT2 are developmentally regulated and tissue-specific. Additionally, the unfolded protein response (UPR) can influence fucosylation, as seen with FUT2-dependent fucosylation of HYOU1 protecting intestinal stem cells. Cellular stress and inflammatory signals can also modulate fucosyltransferase expression. Furthermore, the elongation of O-fucose glycans by POGLUT1 and B3GLCT is tightly regulated and can be influenced by the availability of donor sugars and the folding state of the target protein.
protein O-linked glycosylation via fucose and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| POFUT1 | Cancer, Notch-related disorders | Knockout in cancer cell lines; xenograft models. |
| POFUT2 | Peters plus syndrome | Patient-derived iPSCs; knock-in of patient mutations. |
| FUT8 | Ciliogenesis defects, cancer | Knockout in ciliated cells; zebrafish models. |
| FUT2 | Inflammatory bowel disease | Intestinal organoids; knockout mice. |
| Haptoglobin | Sepsis | Knockout mice; sepsis models. |
Cancer and Immune Evasion
Altered O-fucosylation is a hallmark of cancer. Tumor cells often display aberrant glycosylation patterns that promote immune evasion and metastasis. For instance, fucosyl-biotinylation has been used to detect tumor antigen-specific T cells, highlighting the role of fucosylation in anti-tumor immunity. Moreover, O-fucosylation enzymes such as POFUT1 and POGLUT1 are implicated in cancer progression through their effects on Notch signaling, which is frequently dysregulated in malignancies.
Inflammatory and Infectious Diseases
O-fucosylation contributes to inflammatory responses. FUT2-dependent fucosylation of HYOU1 protects intestinal stem cells against inflammatory injury by regulating the unfolded protein response, suggesting a protective role in inflammatory bowel disease. In sepsis, fucosylated haptoglobin promotes inflammation via the Mincle receptor, identifying a potential therapeutic target. Additionally, fucosylation is involved in allergic immune responses, as shown by the correlation between N-glycan GnGnXF3 and allergic reaction to Juniperus ashei pollen.
Developmental Disorders and Ciliopathies
Defects in O-fucosylation cause congenital disorders. Mutations in POFUT2 and B3GLCT lead to Peters plus syndrome, characterized by eye anomalies, cleft lip/palate, and skeletal defects. FUT8-mediated core fucosylation stabilizes TMEM67 to promote ciliogenesis, linking fucosylation to ciliary function and ciliopathies. These findings underscore the importance of O-fucosylation in development and tissue morphogenesis.
From protein O-linked glycosylation via fucose-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of POFUT1 affect Notch signaling? | POFUT1 knockout cell lines (e.g., HEK293T). |
| How does a point mutation in POFUT2 alter substrate specificity? | CRISPR knock-in of point mutations in POFUT2. |
| Can O-fucosylation of a specific protein be tracked in live cells? | Knock-in of tagged POFUT2 or substrate with fluorescent tag. |
| What is the effect of POFUT1 overexpression on cancer cell proliferation? | Overexpression of POFUT1 in cancer cell lines. |
| Which genes regulate O-fucosylation in intestinal stem cells? | CRISPR library screening in organoids. |
| Does fucosylation of HYOU1 protect against ER stress? | FUT2 knockout intestinal organoids. |
How to Study the protein O-linked glycosylation via fucose Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Glycoproteomics (LC-MS/MS) | Identification and quantification of O-fucosylated peptides | Mapping O-fucosylation sites on proteins. |
| Fucosyl-biotinylation | Labeling of fucosylated proteins for detection | Detecting tumor antigen-specific T cells. |
| CRISPR knockout screening | Genes required for O-fucosylation | Identifying regulators in organoids. |
| Lectin-based flow cytometry | Cell surface fucosylation levels | Immune cell profiling. |
| Western blot with fucose-specific lectin | Protein-specific fucosylation | Validating O-fucosylation of targets. |
| RNA-seq | Transcriptional changes upon O-fucosylation perturbation | Pathway analysis. |
| Immunofluorescence | Subcellular localization of fucosylated proteins | Ciliogenesis studies. |
| Site-directed mutagenesis | Functional consequences of specific O-fucosylation sites | Notch signaling assays. |
Glycoproteomics and Mass Spectrometry
Mass spectrometry-based glycoproteomics enables site-specific identification and quantification of O-fucosylated proteins. By enriching fucosylated peptides using lectins or chemical probes, researchers can map O-fucosylation sites and assess changes under different conditions. This method is powerful for discovering novel substrates and understanding the O-fucosylome in health and disease.
Fucosyl-Biotinylation for Detection
Fucosyl-biotinylation is a chemoenzymatic approach that labels fucosylated proteins with biotin, allowing detection and isolation. This technique has been used to identify tumor antigen-specific T cells via interaction-dependent fucosyl-biotinylation, demonstrating its utility in immunology and cancer research.
CRISPR Screening and Functional Genomics
CRISPR-based knockout screens can systematically identify genes required for O-fucosylation and its downstream effects. For example, a genome-wide screen in intestinal organoids could reveal regulators of FUT2-dependent fucosylation. Such screens are complemented by RNA-seq and proteomics to dissect pathways.
Imaging and Lectin-Based Assays
Lectin-based imaging using fucose-specific lectins (e.g., UEA-I, AAL) allows visualization of O-fucosylation in cells and tissues. This method is useful for assessing the subcellular localization of fucosylated proteins and for high-content screening.
How CRISPR Can Be Used to Study GO:0036066 protein O-linked glycosylation via fucose
Knockout
CRISPR knockout of O-fucosylation genes such as POFUT1, POFUT2, FUT8, and FUT2 allows researchers to study loss-of-function phenotypes. For example, POFUT1 knockout cells exhibit defective Notch signaling and altered differentiation. Knockout models are essential for validating gene function and identifying downstream targets.
Point Mutation
Introducing precise point mutations in O-fucosylation enzymes via CRISPR can dissect catalytic activity, substrate specificity, and protein-protein interactions. For instance, mutations in POFUT2 that cause Peters plus syndrome can be modeled to understand disease mechanisms.
Knock-in
Knock-in of tagged versions of O-fucosylation enzymes or substrates (e.g., GFP-POFUT1) enables live-cell imaging and proteomic analysis. This approach helps track the localization and dynamics of O-fucosylation in real time.
Overexpression
Overexpression of O-fucosylation genes, such as FUT8 or POFUT1, can reveal gain-of-function phenotypes, including enhanced ciliogenesis or altered cancer cell behavior. Overexpression models are useful for studying the effects of elevated fucosylation in disease contexts.
How EDITGENE Supports protein O-linked glycosylation via fucose Research
Researchers studying protein O-linked glycosylation via fucose-related genes often need to determine whether a candidate gene is causally involved in the modification, how mutations affect enzyme function, and what downstream pathways are impacted. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and scale.
Contact EDITGENE today to design your custom CRISPR model for protein O-linked glycosylation via fucose research.
Frequently Asked Questions About protein O-linked glycosylation via fucose
What is protein O-linked glycosylation via fucose?
It is a post-translational modification where fucose is attached to serine or threonine residues on proteins, often within EGF-like or thrombospondin type-1 repeats, as defined by GO:0036066.
What genes are involved in protein O-linked glycosylation via fucose?
Key genes include POFUT1, POFUT2, POGLUT1, B3GLCT, FUT8, and FUT2, which encode enzymes that add or elongate fucose on proteins.
Which diseases are linked to O-fucosylation defects?
Defects are associated with Peters plus syndrome, Dowling-Degos disease, cancer, inflammatory bowel disease, and sepsis.
How is O-fucosylation studied in the lab?
Common methods include glycoproteomics, fucosyl-biotinylation, lectin-based assays, and CRISPR screens.
What is the role of POFUT1 in Notch signaling?
POFUT1 adds fucose to Notch receptors, which is required for ligand binding and activation of downstream signaling.
Can CRISPR be used to study O-fucosylation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in O-fucosylation pathways.
What is the difference between O-fucosylation and N-fucosylation?
O-fucosylation attaches fucose to serine/threonine, while N-fucosylation modifies asparagine-linked glycans; they are distinct processes with different enzymes.
Which proteins are commonly O-fucosylated?
Notch receptors, thrombospondin type-1 repeat proteins, and proteins with EGF-like repeats are common targets.
How does O-fucosylation affect protein function?
It can influence protein folding, stability, trafficking, and interactions, particularly in Notch signaling and ciliogenesis.
What services does EDITGENE offer for O-fucosylation research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, library screening, and bioinformatics services.
Conclusion
Protein O-linked glycosylation via fucose (GO:0036066) is a critical post-translational modification that regulates diverse biological processes, from Notch signaling to intestinal homeostasis and ciliogenesis. Its dysregulation is implicated in cancer, inflammatory diseases, and developmental disorders, making it a vibrant area of research. By leveraging CRISPR-based models and advanced glycoproteomic methods, researchers can uncover new insights into the mechanisms and therapeutic potential of O-fucosylation. EDITGENE stands ready to support these efforts with tailored gene editing and screening services.
References
- 1. Liu Z et al.. 2020. Detecting Tumor Antigen-Specific T Cells via Interaction-Dependent Fucosyl-Biotinylation.. Cell 183(4):1117-1133.e19 PMID: 33096019
- 2. Holdener BC et al.. 2019. Protein O-fucosylation: structure and function.. Curr Opin Struct Biol 56:78-86 PMID: 30690220
- 3. Wang Z et al.. 2023. FUT2-dependent fucosylation of HYOU1 protects intestinal stem cells against inflammatory injury by regulating unfolded protein response.. Redox Biol 60:102618 PMID: 36724577
- 4. Wang D et al.. 2025. FUT8-mediated core fucosylation stabilizes TMEM67 to promote ciliogenesis.. J Cell Biol 224(10) PMID: 40728580
- 5. Roh T et al.. 2025. Fucosylated haptoglobin promotes inflammation via Mincle in sepsis: an observational study.. Nat Commun 16(1):1342 PMID: 39904983
- 6. Álvarez J et al.. 2025. Correlation Between N-Glycan GnGnXF3 and the Allergic Immune Response Against Juniperus ashei Pollen.. Allergy 80(7):1935-1944 PMID: 39912313
- 7. Hao H et al.. 2025. Protein O-Fucosyltransferases: Biological Functions and Molecular Mechanisms in Mammals.. Molecules 30(7) PMID: 40286076
- 8. Tsukamoto Y et al.. 2025. Differential O-glucose elongation on a specific EGF repeat within the canonical ligand-binding domain regulates DLL1/4-NOTCH1 signaling.. Proc Natl Acad Sci U S A 122(43):e2504827122 PMID: 41129232
